How many etiological subtypes of breast cancer: two, three, four, or more?
about
Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State.Potential of breastmilk analysis to inform early events in breast carcinogenesis: rationale and considerationsMetabolic history impacts mammary tumor epithelial hierarchy and early drug response in mice.Computational approach for deriving cancer progression roadmaps from static sample data.Coffee and tea consumption and risk of pre- and postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort studyLatest updates on antiretinal autoantibodies associated with vision loss and breast cancer.The impact of eliminating age inequalities in stage at diagnosis on breast cancer survival for older womenObesity, body fat distribution, and risk of breast cancer subtypes in African American women participating in the AMBER ConsortiumDNA Methylation Patterns Can Estimate Nonequivalent Outcomes of Breast Cancer with the Same Receptor Subtypes.Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells.Inhibition of S-adenosylhomocysteine hydrolase decreases cell mobility and cell proliferation through cell cycle arrest.The in vitro immunogenic potential of caspase-3 proficient breast cancer cells with basal low immunogenicity is increased by hypofractionated irradiationRelationship of Predicted Risk of Developing Invasive Breast Cancer, as Assessed with Three Models, and Breast Cancer Mortality among Breast Cancer PatientsRacial and ethnic disparities in the impact of obesity on breast cancer risk and survival: a global perspective.Breast cancer in Iraq is associated with a unimodally distributed predominance of luminal type B over luminal type A surrogates from young to old ageSuppressing NRIP1 inhibits growth of breast cancer cells in vitro and in vivo.Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER Consortium.Important Role of Menarche in Development of Estrogen Receptor-Negative Breast Cancer in African American WomenDistinct breast cancer characteristics between screen- and self-detected breast cancers recorded in the Japanese Breast Cancer RegistryBreast Cancer beyond the Age of Mutation.Multiplexed immunofluorescence delineates proteomic cancer cell states associated with metabolismActive smoking and risk of Luminal and Basal-like breast cancer subtypes in the Carolina Breast Cancer Study.DNA methylation and breast tumor clinicopathological features: The Western New York Exposures and Breast Cancer (WEB) studyPost-diagnosis adiposity and survival among breast cancer patients: influence of breast cancer subtype.Genetic variations in vitamin D-related pathways and breast cancer risk in African American women in the AMBER consortiumFunctional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer.BMI, reproductive factors, and breast cancer molecular subtypes: A case-control study and meta-analysis.Genetic modifiers of CHEK2*1100delC-associated breast cancer risk.Influence of the C5a-C5a receptor system on breast cancer progression and patient prognosis.Investigating Associations Between Health-Related Quality of Life and Endocrine Therapy Underuse in Women With Early-Stage Breast Cancer.Deciphering and Targeting Oncogenic Mutations and Pathways in Breast Cancer.Age at diagnosis, obesity, smoking, and molecular subtypes in muscle-invasive bladder cancer.Obesity and Breast Cancer.Imputing estrogen receptor (ER) status in a population-based cancer registry: a sensitivity analysis.Investigation of breast cancer sub-populations in black and white women in South Africa.Cancer subtypes in aetiological research.Metrics for monitoring cancer inequities: residential segregation, the Index of Concentration at the Extremes (ICE), and breast cancer estrogen receptor status (USA, 1992-2012).Night work and breast cancer risk defined by human epidermal growth factor receptor-2 (HER2) and hormone receptor status: A population-based case-control study in France.What is in a name? Does cancer subtyping help or hinder in epidemiology research?Endometrial Cancer Risk Factors, Hormone Receptors, and Mortality Prediction.
P2860
Q27300459-D0A3328E-A025-47C7-970E-480239B85E6FQ28067818-8A5B7359-FA58-40FB-8D1A-A867DC468814Q30390384-A28F270F-59AD-49BD-A1A1-FEF282DB866FQ33701691-23040322-5E2C-4A96-A439-5ED39AB0DD4EQ34043072-AAB3EC1C-859E-4C24-8820-610E0B1ABC24Q35161069-18492374-8B54-4C64-B970-4568044AED1AQ35275317-ECBC63A0-8B0C-496C-9A94-B3997A96B4F8Q35634515-BA37A174-4B21-4B90-A513-CCEE32E0D60FQ35835922-BC9889DA-3D0A-4A86-8C50-4CA994BF34C1Q35849077-F31A28E8-2001-478A-A4BC-2F5162EECEE4Q35993101-49B9D43B-AB46-4388-AD7C-78E5943B8F94Q36069982-2A32D544-A6F1-423A-8307-FC23721F3D5AQ36112872-87FE8518-B24E-42C0-B32A-91C5EFE20A77Q36273231-A58E95EF-2EA8-45E2-9470-063FB5C185F1Q36340427-49BA23D5-FB1A-4490-9DC8-F19406E11438Q36545461-BF80CE05-0BD2-481B-B44C-448E38A99D9DQ36655887-C5E3EEDD-8EC9-4A34-80BD-10E8B1A50E92Q36812955-4120EEDF-ECC7-4B57-ADDB-F1534C01C519Q36814415-1DFDF71C-8565-4EB4-91BA-BC538C5FAC3EQ36880525-F836D9C6-C59B-4723-A8A6-386FD696832BQ36891604-A828C2B6-B5E7-4430-8DA8-B0CA4A1919BFQ37270236-7377D5E5-50AC-44A4-830D-3BA1E2A99B2BQ37308097-75DE9CDC-B582-4D37-8DD0-B493FE783E35Q37326372-00B89D4A-1D13-46C3-8FAB-9628D3C2EB8EQ37381735-6F7141F4-E3CE-4AF7-86DF-253A5E55FDE1Q37457902-DA1ED23D-E2B3-456D-BD72-5F1201B9AA44Q37733409-4A46C745-AC16-4DAD-B543-20980DA45185Q37739048-B0F1664C-6514-4A3B-BD57-237ED597AC69Q38736616-08B9598C-71EE-4DFA-9AF7-D9B0B95F659FQ38746104-5CC59C2E-9673-418A-9898-7285B3D0EC7FQ38888022-EF73A788-3AD0-4CD8-B2FA-B58DE23F8F77Q38891922-E2ED0425-0CC8-4F31-9910-93A5A75EB282Q39026644-B28DF819-2359-4AD2-B0FB-0B07AAAAB683Q39127680-F2893518-780C-41F5-BEBA-A60A5086DEBAQ39273326-E5D5C2BB-BBF1-49EC-B273-689775B73EB1Q39397286-981FE60C-CC5E-4CE5-9530-AB79DE153912Q39510045-8E918704-3F0A-4286-82F8-1360BB5EBF60Q39850850-85071880-B143-4FC9-ACD4-C75867A5EDDCQ40141643-39B4B7A2-47E2-46BB-BF5E-37CBD31BB204Q40396155-CEBF0D0A-89A2-4461-8D2A-FAB5131CF123
P2860
How many etiological subtypes of breast cancer: two, three, four, or more?
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
How many etiological subtypes of breast cancer: two, three, four, or more?
@ast
How many etiological subtypes of breast cancer: two, three, four, or more?
@en
How many etiological subtypes of breast cancer: two, three, four, or more?
@nl
type
label
How many etiological subtypes of breast cancer: two, three, four, or more?
@ast
How many etiological subtypes of breast cancer: two, three, four, or more?
@en
How many etiological subtypes of breast cancer: two, three, four, or more?
@nl
prefLabel
How many etiological subtypes of breast cancer: two, three, four, or more?
@ast
How many etiological subtypes of breast cancer: two, three, four, or more?
@en
How many etiological subtypes of breast cancer: two, three, four, or more?
@nl
P2860
P50
P356
P1476
How many etiological subtypes of breast cancer: two, three, four, or more?
@en
P2093
Mark E Sherman
William F Anderson
P2860
P356
10.1093/JNCI/DJU165
P407
P577
2014-08-12T00:00:00Z